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Background: The aim of this study was to identify whether diastolic dysfunction 
predicts in-hospital death in ischemic stroke patients with atrial fibrillation.  
Method: We retrospectively analyzed data from enrolled patients with ischemic stroke 
patients with atrial fibrillation who presented within 24 h of onset. All patients 
underwent transthoracic echocardiography to evaluate diastolic filling pressure 
estimated as the ratio of early transmitral flow velocity (E) to mitral annular velocity 
(e’) within 24 h of admission. We evaluated initial ischemic lesion volume and National 
Institute of Health Stroke Scale (NIHSS) score. 
Results: Two hundred and sixty-six patients were enrolled. During hospitalization, 30 
patients (11%) died. The deceased group had a higher NIHSS score, a higher D-dimer 
level, a higher creatinine level, a larger initial ischemic lesion volume and a higher E/e' 
ratio than those in the survival group. In a multivariate analysis, a higher E/e’ ratio was 
an independent predictor of in-hospital death. The cutoff value for the E/e’ ratio for 
prediction in-hospital death was 20 with the sensitivity of 75% and specificity of 86%.  
Conclusion: Diastolic dysfunction may be associated with in-hospital death in ischemic 
 3 
stroke patients with atrial fibrillation. 






Cardioembolic stroke due to atrial fibrillation (AF) is a common cause of ischemic 
stroke and is associated with high mortality or morbidity with subsequent disability [1–
3]. Furthermore, AF is one of the strongest predictors of in-hospital mortality among 
patients with acute ischemic stroke [4]. Several factors may contribute to in-hospital 
mortality after cardioembolic stroke due to AF, such as larger infarcts, older age, and 
elevated plasma brain natriuretic peptide (BNP) level [5,6]. Diastolic dysfunction is 
caused by an abnormality of diastolic distensibility, filling, or relaxation of the left 
ventricle during diastole [7,8]. Heart failure related to diastolic dysfunction has a 
considerably high mortality even in patients with preserved left ventricular ejection 
fraction [9,10]. Recently, Jang et al reported that heart failure with normal ejection 
fraction was associated with increased risk of ischemic stroke and death in patients with 
AF [11]. This study investigated whether diastolic dysfunction was independently 





Between September 2008 and August 2013, we studied patients admitted 
consecutively with acute ischemic stroke patients with atrial fibrillation within 24 h of 
onset. We excluded patients with transient ischemic attack and those with prior mitral 
valve surgery. In-hospital death was defined as any cause of mortality during 
hospitalization. Patients with modified Rankin scale > 2 were defined as having 
dependence. We divided patients into two groups: the deceased group and the survival 
group. The study was approved by the institutional review board at the Nagasaki 
University Hospital (Nagasaki, Japan). 
 Stroke neurologists made the diagnosis of acute ischemic stroke. Computed 
tomography (CT) was performed in patients with a contraindication for magnetic 
resonance imaging (MRI). The other patients underwent MRI. Ischemic lesion volumes 
on diffusion-weighted magnetic resonance imaging (DWI) were calculated by 
multiplying the area of abnormal intensity outlined manually by slice thickness. The 
abnormal lesions on DWI were visually defined by comparison with the contralateral 
non-affected hemisphere. The window level and window width were chosen to obtain 
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the best contrast between the lesion and the surrounding normal tissues. The occlusion 
sites were diagnosed based on CT angiography or MR angiography. Considerable 
hemorrhagic transformation was defined as a parenchymal hematoma type 2 (PH2; a 
dense hematoma in >30% of the infarcted area with a substantial space-occupying effect, 
or any hemorrhagic lesion outside the infarcted area) [12]. Electrocardiography (ECG), 
continuous ECG monitoring, and 24-h Holter ECG were used to attempt to document 
AF. We examined carotid duplex ultrasonography, ECG, transcranial Doppler, 
transthoracic echocardiography, transesophageal echocardiography, CT and/or MRI, and 
MR angiography and/or CT angiography to identify the mechanism of stroke. 
The following patient characteristics were recorded: age, sex, previous 
ischemic heart disease and ischemic stroke, and vascular risk factors (hypertension, 
diabetes mellitus, hyperlipidemia, and smoking). Hypertension was defined as the use 
of antihypertensive agents, a systolic blood pressure of >140 mm Hg, or a diastolic 
blood pressure of >90 mm Hg. Diabetes was defined as the use of oral hypoglycemic 
agents or insulin, or a glycosylated hemoglobin level of >6.5%. Dyslipidemia was 
defined as the use of antihyperlipidemic agents or a serum cholesterol level of >220 
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mg/dL. Smoking was defined as having smoked cigarettes within the last 5 years. The 
National Institutes of Health Stroke Scale (NIHSS) score was used to assess stroke 
severity. All patients underwent blood tests on admission. The main variables were 
brain natriuretic peptide (BNP), prothrombin time-international normalized ratio, total 
cholesterol, C-reactive protein (CRP), glucose, D-dimer, and creatinine.  
Patients who presented to our hospital within 4.5 h of symptom onset were 
treated with IV rt-PA if there were no contraindications. Furthermore, if both a clinical 
examination with initial NIHSS score > 8 and clinical-DWI mismatch (clinical deficit 
out of proportion to DWI lesion, approximately < 70 ml volume core infarct by visual 
inspection) with concomitant large-vessel occlusion (intracranial internal carotid artery, 
middle cerebral artery M1, and Basilar artery) on MR angiography were found, 
endovascular recanalization therapy was performed using a MERCI device (Concentric 
medical Inc., Fremont, CA) or the Penumbra Aspiration System (Penumbra Inc., 




All patients underwent transthoracic echocardiography, which was examined by an 
experienced sonographer (AT), who was blinded to a patient’s clinical background, 
within 24 h of hospital arrival. Patients were imaged in the left decubitus position with a 
commercially available system (iE33, Philips Ultrasound, Bothell, WA, USA; Vivid 7; 
GE Healthcare, Milwaukee, WI). Diastolic function was assessed by diastolic filling 
pressure, which was estimated as the ratio of early transmitral flow velocity (E) to 
mitral annular velocity (e’) at the septal mitral annulus (E/e’) on transthoracic 
echocardiography [13]. We also measured left atrial diameter and left ventricular 
ejection fraction. To determine inter-rater reliability, a second transthoracic 
echocardiography was performed within 24 h among 90 patients (34%).  
 
Analysis 
Clinical and imaging baseline parameters were compared between the deceased and the 
survival group using the Mann–Whitney U test to analyze numerical variables and the 
Fisher exact test to analyze categorical variables. The data were presented as median 
(interquartile range [IQR]) or frequency (%). To identify independent predictors of 
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in-hospital death, multivariate logistic regression analysis with backward elimination 
method was performed. We included variables, which were significantly associated with 
in-hospital death in the univariate analysis (P<0.1), in the multivariate model. Moreover, 
following variables were forced into the model since they were a priori known as 
clinical strong predictors related to clinical outcome: age, initial NIHSS score, initial 
DWI ischemic lesion volume. We conducted a sensitivity-specificity curve analysis to 
clarify an optimal threshold value of E/e’ ratio for predicting in-hospital death. We also 
calculated sensitivity, specificity, positive predictive value (PPV), and negative 
predictive value (NPV) if we used the optimal threshold value to predict in-hospital 
death at admission. Results were considered significant when the P value was less than 
0.05. All analyses were performed using IBM SPSS software for Windows, version 18 
(SPSS Inc., Chicago, IL, USA). 
 
Results 
Of 266 enrolled patients, 145 were male (55%), with a median age of 79 years (IQR, 
70–85 years), a median NIHSS score of 13 (IQR, 5–20) and a median length of hospital 
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stay of 19 days (IQR, 15–26). Thirty patients (11%) died during hospitalization. The 
causes of death were as follows: brain edema, 25; congestive heart failure, 2; respiratory 
failure, 2; acute myocardial infarction, 1. Their median length of hospital stay was 4 
days (IQR 3-9). The intervals of time from onset to first transthoracic echocardiography 
were similar between the two groups (median, 86 versus 89 min; P=0.797). 
Twenty-three patients (9%) underwent only CT because of pacemaker implantation. 
 The results of the univariate analysis are shown in Table 1. The deceased 
group had a higher initial NIHSS score (median, 20 versus 10; P<0.001), a shorter time 
from onset to admission (median, 106 minutes versus 145 minutes; P=0.024), a higher 
D-dimer level (median, 3.3 versus 1.8 μg/mL; P=0.008), a higher creatinine level 
(median, 1.00 versus 0.86 mg/dL; P=0.022), higher prevalence of internal carotid artery 
occlusion (62 versus 13 %; P<0.001), lower prevalence of middle cerebral artery M2 
occlusion (8 versus 28 %; P=0.031), a larger initial ischemic lesion volume on DWI 
(median, 107 versus 8 mL; P<0.001), were more likely to have a parenchymal 
hemorrhage type 2 (64 versus 3 %; P<0.001), and had a higher E/e’ ratio (median, 23 
versus 14; P=0.001) than those in the survival group. Inter-rater reliability was excellent 
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for the E/e’ ratio with an intraclass coefficients of 0.819. The E/e’ ratio was weakly 
correlated with initial ischemic lesion volume (r=0.226, p=0.006).  
 Age, initial NIHSS score, D-dimer, glucose, creatinine, C-reactive protein, 
brain natriuretic peptide, albumin, internal carotid artery occlusion, initial ischemic 
lesion volume on DWI, and E/e’ ratio were chosen as possible predictors associated 
with in-hospital death. Multivariate logistic regression analysis with backward 
elimination method demonstrated that the E/e’ ratio (odds ratio, 1.181; 95% confidence 
interval, 1.025–1.361; P=0.021) was an independent predictor of in-hospital death 
(Table 2). A sensitivity-specificity curve analysis revealed an optimal threshold value of 
the E/e’ ratio for predicting in-hospital death. The optimal threshold value was 20 




Diastolic dysfunction was an independent predictor of in-hospital death after acute 
ischemic stroke with AF. The NPV of an E/e’ ratio >20 was 98%. Furthermore, the 
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mortality rate was 25% for patients with an E/e’ ratio ≥20, but only 2% for patients with 
an E/e’ ratio < 20.  
Possible explanations for the association between a high E/e’ ratio and 
in-hospital death include: First, patients with a high E/e’ ratio tend to have a large 
ischemic lesion. Consequently, that may develop fetal brain edema. Actually, a high E/e’ 
ratio was correlated to initial ischemic lesion volume on DWI in this study. Iwakura et 
al. reported that diastolic dysfunction was associated with left atrial appendage 
thrombus in patients with AF [14]. Transesophageal echocardiography sometimes 
demonstrates large thrombus in left atrium in patients with AF. Therefore, a large 
thrombus in the left atrium may form a large ischemic lesion because of occlusion of a 
main artery of the brain. Second, diastolic dysfunction was independently associated 
with decreased exercise left ventricular systolic performance represented by the systolic 
index and cardiac index [15]. Oxygen supply may be unsatisfactory at the misery 
perfusion area, located around the ischemic core, in patients with diastolic dysfunction. 
Consequently, progression of the ischemic core in patients with diastolic dysfunction 
could be more apparent than that in patients with normal diastolic function. Third, 
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deceased patients may have already developed heart failure at presentation. A 
retrospective cohort study demonstrated a more than doubled risk of in-hospital death 
after stroke for chronic heart failure patients compared with stroke patients without 
chronic heart failure [16]. 
   In this study, initial DWI ischemic lesion volume was not an independent predictor 
of in-hospital death among acute ischemic stroke patients with AF. Large acute DWI 
lesion volume predicts early neurological deterioration including death in patients with 
middle cerebral artery or intracranial internal carotid artery occlusion [17]. The reason 
for this may be that we included patients who suffered both anterior and posterior 
circulation ischemic stroke. The infarct volume formed in the posterior circulation area 
is generally smaller than that in the anterior circulation.   
   Plasma BNP level did not relate to in-hospital death in this study. Shibazaki et al. 
reported that high plasma BNP level predicted in-hospital death in acute ischemic stroke 
and TIA patients with AF [6]. According to Keyzer et al, BNP values among elderly 
subjects were higher than those among younger subjects [18]. In our study, age of 
patients in both groups was higher than that in their study. Moreover, there was no 
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significant difference between two groups in the median age.  
   Although some previous studies have indicated that low serum albumin [19], high 
plasma CRP [20], and hyperglycemia [21] are correlated to early death after acute 
ischemic stroke, multivariate logistic regression analysis in our study did not verify a 
correlation like that in previous reports. It has been previously reported that stroke 
severity indexed by the NIHSS score is an important predictor of mortality in all types 
of acute ischemic stroke [22,23]. Our study included cardioembolic stroke patients with 
AF and did not support those results. 
   There were some limitations in our study. We performed a retrospective analysis of 
prospectively collected data with a small sample size. This may result in a type 2 error. 
Multiple comparisons can lead to a type 1 error. Several cardiologists performed the 
second transthoracic echocardiography. However, inter-rater reliability was excellent.  
 
Conclusions 
   Diastolic dysfunction may be associated with in-hospital death in ischemic stroke 
patients with atrial fibrillation. Clarification of diastolic dysfunction at presentation 
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might support clinicians in clinical practice. Further study is warranted to improve 
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  Deceased group 
n = 30 
Survival group 
n = 236 
p value 
Age, y median (IQR)  80 (75-85)   79 (69-86)  0.319* 
Gender (M/F)  13/17   132/104  0.243† 
Past medical history n (%)          
 Ischemic stroke   7 (23)   55 (24)  1.000† 
 Ischemic heart disease   5 (18)   29 (12)  0.380† 
 Renal dialysis   1 (4)   3 (1)  0.363† 
Vascular risk factors n (%)          
 23 
 Hypertension   23 (77)   187 (80)  0.637† 
 Diabetes mellitus   8 (27)   52 (22)  0.643† 
 Dyslipidemia   7 (23)   53 (23)  1.000† 
 Smoking   3 (10)   54 (23)  0.152† 
Medication before admission n (%)          
 Antiplatelet agent   13 (45)   68 (29)  0.090† 
 Anticoagulant agent   9 (32)   71 (30)  0.831† 
Dependence before admission   5 (17)   30 (13)  0.566† 
Time from onset to admission, min median (IQR)  106 (60-165)   145 (79-458)  0.024* 
Initial NIHSS score median (IQR)  20 (18-23)   10 (4-18)  < 0.001* 
 24 
Laboratory findings median (IQR)          
 BNP, pg/mL   246 (135-395)   237 (138-395)  0.837* 
 D-dimer, µg/mL   3.3 (1.1-7.0)   1.8 (0.9-3.6)  0.008* 
 PT-INR   1.05 (0.98-1.18)   1.06 (1.00-1.18)  0.656* 
 Glucose, mg/dL   156 (109-188)   124 (108-154)  0.053* 
 Total cholesterol, mg/dL   168 (151-199)   171 (153-198)  0.684* 
 C-reactive protein, mg/dL   0.18 (0.04-0.80)   0.19 (0.07-0.75)  0.150* 
 Albumin, mg/dL   3.8 (3.4-4.0)   3.8 (3.5-4.0)  0.935* 
 Creatinine, mg/dL   1.00 (0.82-1.32)   0.86 (0.71-1.07)  0.022* 
Location of vessel occlusion n (%)          
 25 
 ICA occlusion   16/26 (62)   28/218 (13)  < 0.001† 
 MCA M1 occlusion   3/26 (12)   36/218 (17)  0.777† 
 MCA M2 occlusion   2/26 (8)   62/218 (28)  0.031† 
 PCA occlusion   0/26 (0)   17/218 (8)  0.229† 
 BA occlusion   2/26 (8)   6/218 (3)  0.205† 
 VA occlusion   0/26 (0)   4/218 (2)  1.000† 
 No occlusion   2/26 (8)   63/218 (29)  0.019† 
 DWI ischemic lesion  
















Table 1.  Comparisons between Groups (Deceased Versus Survival) 
Transthoracic echocardiography           
 Left atrial diameter, mm median (IQR)  42 (35-47)   42 (37-47)  0.610* 
 EF<40% n (%)  4 (17)   18 (7)  0.109† 
 E/e’ median (IQR)  23 (20-29)   14 (11-18)  0.001* 
Acute stroke treatment n (%)          
 IV tPA   7 (23)   47 (20)  0.635† 
 Endovascular therapy   5 (17)   16 (7)  0.071† 
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IQR indicates interquartile range; NIHSS, National Institutes of Health Stroke Scale; BNP, brain natriuretic peptide; PT-INR, 
prothrombin time-international normalized ratio; ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior cerebral 
artery; BA, basilar artery; VA, vertebral artery; DWI, diffusion-weighted imaging; PH, parenchymal hematoma; EF, ejection fraction; 
and tPA, tissue-type plasminogen activator. 
*Mann-Whitney U test. 
†Fisher’s exact test. 
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 p value odds ratio 95% confidence interval 
ICA occlusion, 0.088 4.695 0.792 – 27.820 
NIHSS score,  0.094 1.139 0.978 – 1.328 
BNP, pg/mL 0.138 0.994 0.987 – 1.002 
E/e’ ratio,  0.021 1.181 1.025 – 1.361 
Table 2.  Predictors of In-Hospital Death: Multivariate Logistic Regression Analysis 
ICA indicates internal carotid artery; NIHSS, National Institutes of Health Stroke Scale; BNP, brain natriuretic peptide.
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Figure 
An optimal threshold value of E/e’ for predicting in-hospital death was 20. The 
sensitivity and specificity were 75% and 83%, respectively 
 
 

